← Human Trials & Peer-Reviewed Studies
Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS
Plain-language guide to PMID 33491091 (2021): crossover randomized controlled trial study of Glucagon and Ghrelin, pcos.
Key Facts
- PMID
- 33491091
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Hoover SE et al. (6 authors)
- DOI
- 10.1210/clinem/dgab028
What This Study Did, in Plain Language
What Was Tested
Researchers studied Glucagon and Ghrelin in the context of pcos in this randomized controlled trial publication.
At each diet midpoint, a solid meal test was administered to examine postprandial ghrelin, glucagon, glucose, insulin, and self-reported appetite scores.
Why It Was Studied
Altered satiety hormones in women with polycystic ovarian syndrome (PCOS) may contribute to obesity.
Diets with a low glycemic load (GL) may influence appetite-regulating hormones including glucagon and ghrelin.
Who Took Part
The age groups tagged for this paper are young adults, adults and middle-aged adults, women only.
Thirty women diagnosed with PCOS.
How the Study Was Run
In design terms this was a randomized and crossover study.
The participants were allocated by chance, so the Glucagon group and the comparison group should start out alike.
In the crossover set-up each of the participants took both Glucagon and the comparison in turn, acting as their own control.
Secondary analysis of a randomized crossover trial.
What Was Measured
Topics PubMed links to this paper include Diet, Energy Intake, Ghrelin, Glucagon, Glycemic Load, Hunger and Polycystic Ovary Syndrome.
Author keywords: appetite and satiety.
What This Means in Plain Language
The paper is a randomized and crossover study of Glucagon and Ghrelin in people with pcos.
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2021 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the Glucagon compound page and the Ghrelin compound page, PCOS research.
Our Notes on the Compounds
Glucagon: A 29-amino-acid pancreatic hormone that raises blood glucose; used as a rescue medicine for severe low blood sugar and as a diagnostic aid.
Ghrelin: A 28-amino-acid stomach hormone that signals hunger and triggers growth hormone release; studied in human trials as an infusion.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.